The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Research Report 2025
Synopsis
Chronic kidney disease mineral bone disorder (MBD) belongs to the bone disease pathology, is characterized by "inadequate bone mineralization" (bonemineralizationdeficiency), which is associated with chronic kidney disease of electrolyte and the direct result of endocrine disorder.
The global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) include Akebia, Astellas, Takeda, Vifor, Abbvie, Fresenius, Abbott, Novadiol and Japan Tobacco Company, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD).
Report Scope
The Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Akebia
Astellas
Takeda
Vifor
Abbvie
Fresenius
Abbott
Novadiol
Japan Tobacco Company
Daiichi-Sankyo
Shield
Spectrum
OPKO
Ardelyx
Sanofi Genzyme
Amgen
Segment by Type
Control Hyperphosphatemia
Maintain Blood Calcium Levels
Control PTH Level
Correct Acidosis
Others
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Drug Stores
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Chronic kidney disease mineral bone disorder (MBD) belongs to the bone disease pathology, is characterized by "inadequate bone mineralization" (bonemineralizationdeficiency), which is associated with chronic kidney disease of electrolyte and the direct result of endocrine disorder.
The global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) include Akebia, Astellas, Takeda, Vifor, Abbvie, Fresenius, Abbott, Novadiol and Japan Tobacco Company, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD).
Report Scope
The Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Akebia
Astellas
Takeda
Vifor
Abbvie
Fresenius
Abbott
Novadiol
Japan Tobacco Company
Daiichi-Sankyo
Shield
Spectrum
OPKO
Ardelyx
Sanofi Genzyme
Amgen
Segment by Type
Control Hyperphosphatemia
Maintain Blood Calcium Levels
Control PTH Level
Correct Acidosis
Others
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Drug Stores
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Overview
1.1 Product Overview and Scope of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD)
1.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Segment by Type
1.2.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Value Comparison by Type (2024-2030)
1.2.2 Control Hyperphosphatemia
1.2.3 Maintain Blood Calcium Levels
1.2.4 Control PTH Level
1.2.5 Correct Acidosis
1.2.6 Others
1.3 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Segment by Application
1.3.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Value by Application: (2024-2030)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.3.5 Drug Stores
1.3.6 Others
1.4 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size Estimates and Forecasts
1.4.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue 2019-2030
1.4.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales 2019-2030
1.4.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Competition by Manufacturers
2.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Manufacturers (2019-2024)
2.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Average Price by Manufacturers (2019-2024)
2.4 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD), Product Type & Application
2.7 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Competitive Situation and Trends
2.7.1 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Players Market Share by Revenue
2.7.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Retrospective Market Scenario by Region
3.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Region: 2019-2030
3.2.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Region: 2019-2024
3.2.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Region: 2025-2030
3.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Region: 2019-2030
3.3.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Region: 2019-2024
3.3.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Region: 2025-2030
3.4 North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Facts & Figures by Country
3.4.1 North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2019-2030)
3.4.3 North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Facts & Figures by Country
3.5.1 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2019-2030)
3.5.3 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Facts & Figures by Country
3.6.1 Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2019-2030)
3.6.3 Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Facts & Figures by Country
3.7.1 Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2019-2030)
3.7.3 Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Facts & Figures by Country
3.8.1 Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2019-2030)
3.8.3 Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2019-2030)
4.1.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2019-2024)
4.1.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2025-2030)
4.1.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Type (2019-2030)
4.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Type (2019-2030)
4.2.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Type (2019-2024)
4.2.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Type (2025-2030)
4.2.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Type (2019-2030)
4.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Price by Type (2019-2030)
5 Segment by Application
5.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2019-2030)
5.1.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2019-2024)
5.1.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2025-2030)
5.1.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Application (2019-2030)
5.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Application (2019-2030)
5.2.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Application (2019-2024)
5.2.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Application (2025-2030)
5.2.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Application (2019-2030)
5.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Akebia
6.1.1 Akebia Corporation Information
6.1.2 Akebia Description and Business Overview
6.1.3 Akebia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Akebia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
6.1.5 Akebia Recent Developments/Updates
6.2 Astellas
6.2.1 Astellas Corporation Information
6.2.2 Astellas Description and Business Overview
6.2.3 Astellas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Astellas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
6.2.5 Astellas Recent Developments/Updates
6.3 Takeda
6.3.1 Takeda Corporation Information
6.3.2 Takeda Description and Business Overview
6.3.3 Takeda Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Takeda Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
6.3.5 Takeda Recent Developments/Updates
6.4 Vifor
6.4.1 Vifor Corporation Information
6.4.2 Vifor Description and Business Overview
6.4.3 Vifor Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Vifor Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
6.4.5 Vifor Recent Developments/Updates
6.5 Abbvie
6.5.1 Abbvie Corporation Information
6.5.2 Abbvie Description and Business Overview
6.5.3 Abbvie Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Abbvie Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
6.5.5 Abbvie Recent Developments/Updates
6.6 Fresenius
6.6.1 Fresenius Corporation Information
6.6.2 Fresenius Description and Business Overview
6.6.3 Fresenius Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Fresenius Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
6.6.5 Fresenius Recent Developments/Updates
6.7 Abbott
6.6.1 Abbott Corporation Information
6.6.2 Abbott Description and Business Overview
6.6.3 Abbott Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Abbott Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
6.7.5 Abbott Recent Developments/Updates
6.8 Novadiol
6.8.1 Novadiol Corporation Information
6.8.2 Novadiol Description and Business Overview
6.8.3 Novadiol Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Novadiol Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
6.8.5 Novadiol Recent Developments/Updates
6.9 Japan Tobacco Company
6.9.1 Japan Tobacco Company Corporation Information
6.9.2 Japan Tobacco Company Description and Business Overview
6.9.3 Japan Tobacco Company Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Japan Tobacco Company Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
6.9.5 Japan Tobacco Company Recent Developments/Updates
6.10 Daiichi-Sankyo
6.10.1 Daiichi-Sankyo Corporation Information
6.10.2 Daiichi-Sankyo Description and Business Overview
6.10.3 Daiichi-Sankyo Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Daiichi-Sankyo Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
6.10.5 Daiichi-Sankyo Recent Developments/Updates
6.11 Shield
6.11.1 Shield Corporation Information
6.11.2 Shield Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Description and Business Overview
6.11.3 Shield Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Shield Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
6.11.5 Shield Recent Developments/Updates
6.12 Spectrum
6.12.1 Spectrum Corporation Information
6.12.2 Spectrum Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Description and Business Overview
6.12.3 Spectrum Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Spectrum Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
6.12.5 Spectrum Recent Developments/Updates
6.13 OPKO
6.13.1 OPKO Corporation Information
6.13.2 OPKO Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Description and Business Overview
6.13.3 OPKO Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2019-2024)
6.13.4 OPKO Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
6.13.5 OPKO Recent Developments/Updates
6.14 Ardelyx
6.14.1 Ardelyx Corporation Information
6.14.2 Ardelyx Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Description and Business Overview
6.14.3 Ardelyx Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Ardelyx Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
6.14.5 Ardelyx Recent Developments/Updates
6.15 Sanofi Genzyme
6.15.1 Sanofi Genzyme Corporation Information
6.15.2 Sanofi Genzyme Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Description and Business Overview
6.15.3 Sanofi Genzyme Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Sanofi Genzyme Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
6.15.5 Sanofi Genzyme Recent Developments/Updates
6.16 Amgen
6.16.1 Amgen Corporation Information
6.16.2 Amgen Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Description and Business Overview
6.16.3 Amgen Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Amgen Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
6.16.5 Amgen Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Industry Chain Analysis
7.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Production Mode & Process
7.4 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Marketing
7.4.1 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Channels
7.4.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Distributors
7.5 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Customers
8 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Dynamics
8.1 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Industry Trends
8.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Drivers
8.3 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Challenges
8.4 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Competitive Situation by Manufacturers in 2023
Table 4. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT) of Key Manufacturers (2019-2024)
Table 5. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Average Price (USD/Kg) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD), Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD), Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD), Product Type & Application
Table 12. Global Key Manufacturers of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD), Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Region (2019-2024) & (MT)
Table 18. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Region (2019-2024)
Table 19. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Region (2025-2030) & (MT)
Table 20. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Region (2025-2030)
Table 21. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Region (2019-2024)
Table 23. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Region (2025-2030)
Table 25. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2019-2024) & (MT)
Table 27. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2025-2030) & (MT)
Table 28. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2019-2024) & (MT)
Table 32. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2025-2030) & (MT)
Table 33. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Region (2019-2024) & (MT)
Table 37. Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Region (2025-2030) & (MT)
Table 38. Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2019-2024) & (MT)
Table 42. Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2025-2030) & (MT)
Table 43. Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2019-2024) & (MT)
Table 47. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2025-2030) & (MT)
Table 48. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT) by Type (2019-2024)
Table 51. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT) by Type (2025-2030)
Table 52. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Type (2019-2024)
Table 53. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Type (2025-2030)
Table 54. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Type (2019-2024)
Table 57. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Type (2025-2030)
Table 58. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Price (USD/Kg) by Type (2019-2024)
Table 59. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Price (USD/Kg) by Type (2025-2030)
Table 60. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT) by Application (2019-2024)
Table 61. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT) by Application (2025-2030)
Table 62. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Application (2019-2024)
Table 63. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Application (2025-2030)
Table 64. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Application (2019-2024)
Table 67. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Application (2025-2030)
Table 68. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Price (USD/Kg) by Application (2019-2024)
Table 69. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Price (USD/Kg) by Application (2025-2030)
Table 70. Akebia Corporation Information
Table 71. Akebia Description and Business Overview
Table 72. Akebia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 73. Akebia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product
Table 74. Akebia Recent Developments/Updates
Table 75. Astellas Corporation Information
Table 76. Astellas Description and Business Overview
Table 77. Astellas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 78. Astellas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product
Table 79. Astellas Recent Developments/Updates
Table 80. Takeda Corporation Information
Table 81. Takeda Description and Business Overview
Table 82. Takeda Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 83. Takeda Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product
Table 84. Takeda Recent Developments/Updates
Table 85. Vifor Corporation Information
Table 86. Vifor Description and Business Overview
Table 87. Vifor Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 88. Vifor Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product
Table 89. Vifor Recent Developments/Updates
Table 90. Abbvie Corporation Information
Table 91. Abbvie Description and Business Overview
Table 92. Abbvie Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 93. Abbvie Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product
Table 94. Abbvie Recent Developments/Updates
Table 95. Fresenius Corporation Information
Table 96. Fresenius Description and Business Overview
Table 97. Fresenius Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 98. Fresenius Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product
Table 99. Fresenius Recent Developments/Updates
Table 100. Abbott Corporation Information
Table 101. Abbott Description and Business Overview
Table 102. Abbott Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 103. Abbott Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product
Table 104. Abbott Recent Developments/Updates
Table 105. Novadiol Corporation Information
Table 106. Novadiol Description and Business Overview
Table 107. Novadiol Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 108. Novadiol Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product
Table 109. Novadiol Recent Developments/Updates
Table 110. Japan Tobacco Company Corporation Information
Table 111. Japan Tobacco Company Description and Business Overview
Table 112. Japan Tobacco Company Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 113. Japan Tobacco Company Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product
Table 114. Japan Tobacco Company Recent Developments/Updates
Table 115. Daiichi-Sankyo Corporation Information
Table 116. Daiichi-Sankyo Description and Business Overview
Table 117. Daiichi-Sankyo Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 118. Daiichi-Sankyo Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product
Table 119. Daiichi-Sankyo Recent Developments/Updates
Table 120. Shield Corporation Information
Table 121. Shield Description and Business Overview
Table 122. Shield Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 123. Shield Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product
Table 124. Shield Recent Developments/Updates
Table 125. Spectrum Corporation Information
Table 126. Spectrum Description and Business Overview
Table 127. Spectrum Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 128. Spectrum Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product
Table 129. Spectrum Recent Developments/Updates
Table 130. OPKO Corporation Information
Table 131. OPKO Description and Business Overview
Table 132. OPKO Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 133. OPKO Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product
Table 134. OPKO Recent Developments/Updates
Table 135. Ardelyx Corporation Information
Table 136. Ardelyx Description and Business Overview
Table 137. Ardelyx Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 138. Ardelyx Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product
Table 139. Ardelyx Recent Developments/Updates
Table 140. Sanofi Genzyme Corporation Information
Table 141. Sanofi Genzyme Description and Business Overview
Table 142. Sanofi Genzyme Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 143. Sanofi Genzyme Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product
Table 144. Sanofi Genzyme Recent Developments/Updates
Table 145. Amgen Corporation Information
Table 146. Amgen Description and Business Overview
Table 147. Amgen Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 148. Amgen Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product
Table 149. Amgen Recent Developments/Updates
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Distributors List
Table 153. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Customers List
Table 154. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Trends
Table 155. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Drivers
Table 156. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Challenges
Table 157. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD)
Figure 2. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Share by Type in 2023 & 2030
Figure 4. Control Hyperphosphatemia Product Picture
Figure 5. Maintain Blood Calcium Levels Product Picture
Figure 6. Control PTH Level Product Picture
Figure 7. Correct Acidosis Product Picture
Figure 8. Others Product Picture
Figure 9. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 10. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Share by Application in 2023 & 2030
Figure 11. Hospital Pharmacies
Figure 12. Retail Pharmacies
Figure 13. Online Pharmacies
Figure 14. Drug Stores
Figure 15. Others
Figure 16. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size (2019-2030) & (US$ Million)
Figure 18. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (2019-2030) & (MT)
Figure 19. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Average Price (USD/Kg) & (2019-2030)
Figure 20. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Report Years Considered
Figure 21. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Share by Manufacturers in 2023
Figure 22. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Share by Manufacturers in 2023
Figure 23. The Global 5 and 10 Largest Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Players: Market Share by Revenue in 2023
Figure 24. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 25. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 26. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Country (2019-2030)
Figure 27. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Country (2019-2030)
Figure 28. U.S. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Canada Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Country (2019-2030)
Figure 31. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Country (2019-2030)
Figure 32. Germany Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. France Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. U.K. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Italy Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Russia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Region (2019-2030)
Figure 38. Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Region (2019-2030)
Figure 39. China Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Japan Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. South Korea Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. India Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Australia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Taiwan Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Indonesia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Thailand Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Malaysia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Philippines Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Country (2019-2030)
Figure 50. Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Country (2019-2030)
Figure 51. Mexico Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Brazil Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Argentina Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Country (2019-2030)
Figure 55. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Country (2019-2030)
Figure 56. Turkey Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 57. Saudi Arabia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 58. U.A.E Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 59. Global Sales Market Share of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) by Type (2019-2030)
Figure 60. Global Revenue Market Share of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) by Type (2019-2030)
Figure 61. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Price (USD/Kg) by Type (2019-2030)
Figure 62. Global Sales Market Share of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) by Application (2019-2030)
Figure 63. Global Revenue Market Share of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) by Application (2019-2030)
Figure 64. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Price (USD/Kg) by Application (2019-2030)
Figure 65. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Value Chain
Figure 66. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Production Process
Figure 67. Channels of Distribution (Direct Vs Distribution)
Figure 68. Distributors Profiles
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
